News Releases
Dec 10 2003
Avanir And Peregrine Execute Commercial License Agreement For Anti-Cancer Antibody
Dec 8 2003
Avid Bioservices To Expand Manufacturing Capacity
Nov 24 2003
Avid Bioservices Signs Manufacturing Supply Agreement For Production Of Recombinant Protein
Nov 19 2003
Peregrine Appoints New Transfer Agent
Nov 18 2003
Avid Bioservices Signs Product Development Agreement With Medipharm Biotech For Tumor Necrosis Therapy
Nov 12 2003
Peregrine's Transfer Agent and DTC Reconcile Shares Held in Trust by DTC
Nov 12 2003
Peregrine Provides Clarification on NASDAQ Trading Halt
Nov 3 2003
Peregrine Researchers Receive $1.68 Million NIAID Biodefense Grant For Research Into The Treatment Of Lassa Fever
Oct 29 2003
Avid Bioservices Signs Manufacturing Supply Agreement For Production Of Monoclonal Antibodies
Oct 17 2003
Peregrine's Phosphatidylserine-Based Vascular Targeting Agent Technology Presented At The American Association For Cancer Research Meeting